Twitter  |    LinkedIn


Dr. Kim is the Sol and Clara Kest Professor of Dermatology, Vice Chair of Research, and Site Chair of Mount Sinai West and Morningside in the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai. He is also Director of the Mark Lebwohl Center for Neuroinflammation and Sensation that is overseen by the Kimberly and Eric J. Waldman Department of Dermatology, Precision Immunology Institute, and the Friedman Brain Institute at Mount Sinai.

Dr. Kim received his M.D. from the University of Washington, was a HHMI-NIH Scholar, completed residency in dermatology at the University of Pennsylvania where he earned a Master of Translational Research (MTR). He has >100 peer-reviewed publications, multiple NIH grants, designed pivotal clinical trials, and is an inventor of itch-centered technologies. His research has led to awards and funding from NIH, Doris Duke Charitable Foundation, American Skin Association, American Academy of Dermatology, American Society for Clinical Investigation, American Dermatological Association, and International League of Dermatological Societies. He holds a patent for the use of JAK inhibitors for itch. He is on the SAB for Abrax Japan, Granular Therapeutics, Recens Medical, National Eczema Association, and Cell Reports Medicine. He is section editor for Journal of Immunology and on the board of reviewing editors for eLife.